Gainers
- ThermoGenesis Holdings (NASDAQ:THMO) stock moved upwards by 39.0% to $0.86 during Wednesday's regular session. The market value of their outstanding shares is at $2.7 million.
- Femasys (NASDAQ:FEMY) shares increased by 21.51% to $1.06. The company's market cap stands at $22.9 million.
- PepGen (NASDAQ:PEPG) stock rose 13.77% to $12.1. The company's market cap stands at $288.1 million.
- Abeona Therapeutics (NASDAQ:ABEO) shares rose 13.48% to $4.88. The company's market cap stands at $120.8 million.
- FibroGen (NASDAQ:FGEN) shares increased by 12.87% to $2.16. The market value of their outstanding shares is at $212.0 million.
- Perspective Therapeutics (AMEX:CATX) stock increased by 12.78% to $0.98. The company's market cap stands at $484.7 million.
Losers
- CytoMed Therapeutics (NASDAQ:GDTC) stock declined by 29.3% to $2.17 during Wednesday's regular session. The market value of their outstanding shares is at $25.0 million.
- Biolase (NASDAQ:BIOL) stock fell 25.69% to $0.38. The market value of their outstanding shares is at $1.3 million.
- Elicio Therapeutics (NASDAQ:ELTX) stock fell 18.69% to $3.09. The company's market cap stands at $29.6 million.
- Biofrontera (NASDAQ:BFRI) stock declined by 18.26% to $0.73. The company's market cap stands at $1.2 million.
- Cingulate (NASDAQ:CING) shares declined by 17.04% to $1.07. The company's market cap stands at $1.5 million.
- Cosmos Health (NASDAQ:COSM) stock fell 15.52% to $0.8. The company's market cap stands at $13.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BFRIBiofrontera Inc
$0.8300-2.80%
CATXPerspective Therapeutics Inc
$2.293.62%
CINGCingulate Inc
$3.402.25%
COSMCosmos Health Inc
$0.71231.76%
ELTXElicio Therapeutics Inc
$8.72-1.95%
FEMYFemasys Inc
$0.7778-9.29%
FGENFibroGen Inc
$8.60-1.15%
GDTCCytoMed Therapeutics Ltd
$2.137.58%
PEPGPepGen Inc
$5.3110.5%
THMOThermoGenesis Holdings Inc
$0.00010-%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
